Cervical Cancer Vaccine, Made In India, To Be Available Soon At Rs 200-400
India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in the affordable price range of Rs 200-400.
Union Minister of Science and Technology Jitendra Singh today attended an event held to announce the scientific completion of the vaccine. Scientific completion implies that the R&D activities pertaining to the vaccine are complete and the next step would be making them available to the public.
Speaking at the event, Mr Singh said Covid has raised awareness about preventive healthcare leading to the development of vaccines like the one against cervical cancer.
"The schemes like Ayushman Bharat have made us think about preventive healthcare and we can now afford it. The Department of Biotechnology has taken a lead in the matter and are in collaborative mode," he said.
Scientific efforts at times do not get the scale of recognition they deserve. So this event is to celebrate that scientific completion," he said.
CEO of the Serum Institute of India (SII) Adar Poonawalla, who was also present, told reporters on the sidelines of the event, "The cervical cancer vaccine will be affordable and would be available in the range of Rs 200-400. However, the final price is yet to be decided".
No comments: